Walgreens Boots Alliance, Inc. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Walgreens Boots Alliance, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q3 2024.
  • Walgreens Boots Alliance, Inc. Operating Income (Loss) for the quarter ending August 31, 2024 was -$977M, a 117% decline year-over-year.
  • Walgreens Boots Alliance, Inc. Operating Income (Loss) for the twelve months ending August 31, 2024 was -$14.1B, a 105% decline year-over-year.
  • Walgreens Boots Alliance, Inc. annual Operating Income (Loss) for 2024 was -$14.1B, a 105% decline from 2023.
  • Walgreens Boots Alliance, Inc. annual Operating Income (Loss) for 2023 was -$6.88B, a 596% decline from 2022.
  • Walgreens Boots Alliance, Inc. annual Operating Income (Loss) for 2022 was $1.39B, a 40.8% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$14.1B -$977M -$526M -117% Jun 1, 2024 Aug 31, 2024 10-K 2024-10-15
Q2 2024 -$13.6B $111M +$588M Mar 1, 2024 May 31, 2024 10-Q 2024-06-27
Q1 2024 -$14.1B -$13.2B -$13.4B -6786% Dec 1, 2023 Feb 29, 2024 10-Q 2024-03-28
Q4 2023 -$770M -$39M +$6.11B +99.4% Sep 1, 2023 Nov 30, 2023 10-Q 2024-01-04
Q3 2023 -$6.88B -$451M +$371M +45.1% Jun 1, 2023 Aug 31, 2023 10-K 2024-10-15
Q2 2023 -$7.25B -$477M -$157M -49.1% Mar 1, 2023 May 31, 2023 10-Q 2024-06-27
Q1 2023 -$7.1B $197M -$1.05B -84.2% Dec 1, 2022 Feb 28, 2023 10-Q 2024-03-28
Q4 2022 -$6.05B -$6.15B -$7.43B -579% Sep 1, 2022 Nov 30, 2022 10-Q 2024-01-04
Q3 2022 $1.39B -$822M -$1.73B -190% Jun 1, 2022 Aug 31, 2022 10-K 2024-10-15
Q2 2022 $3.12B -$320M -$1.45B -128% Mar 1, 2022 May 31, 2022 10-Q 2023-06-27
Q1 2022 $4.57B $1.25B +$414M +49.8% Dec 1, 2021 Feb 28, 2022 10-Q 2023-03-28
Q4 2021 $4.16B $1.28B +$1.82B Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-05
Q3 2021 $2.34B $911M +$395M +76.6% Jun 1, 2021 Aug 31, 2021 10-K 2023-10-12
Q2 2021 $1.95B $1.13B +$2.82B Mar 1, 2021 May 31, 2021 10-Q 2022-06-30
Q1 2021 -$870M $832M -$304M -26.8% Dec 1, 2020 Feb 28, 2021 10-Q 2022-03-31
Q4 2020 -$566M -$535M -$1.55B -153% Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-06
Q3 2020 $982M $516M -$130M -20.1% Jun 1, 2020 Aug 31, 2020 10-K 2022-10-13
Q2 2020 $1.11B -$1.68B -$2.89B -240% Mar 1, 2020 May 31, 2020 10-Q 2021-07-01
Q1 2020 $4B $1.14B -$381M -25.1% Dec 1, 2019 Feb 29, 2020 10-Q 2021-03-31
Q4 2019 $4.38B $1.01B -$387M -27.6% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-07
Q3 2019 $4.77B $646M -$750M -53.7% Jun 1, 2019 Aug 31, 2019 10-K 2021-10-14
Q2 2019 $5.52B $1.2B -$394M -24.7% Mar 1, 2019 May 31, 2019 10-Q 2020-07-09
Q1 2019 $5.91B $1.52B -$460M -23.3% Dec 1, 2018 Feb 28, 2019 10-Q 2020-04-02
Q4 2018 $6.37B $1.4B +$81M +6.14% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-08
Q3 2018 $6.29B $1.4B +$355M +34.1% Jun 1, 2018 Aug 31, 2018 10-K 2020-10-15
Q2 2018 $5.93B $1.6B +$80M +5.27% Mar 1, 2018 May 31, 2018 10-Q 2019-06-27
Q1 2018 $5.85B $1.98B +$498M +33.7% Dec 1, 2017 Feb 28, 2018 10-Q 2019-04-02
Q4 2017 $5.36B $1.32B -$128M -8.85% Sep 1, 2017 Nov 30, 2017 10-Q 2018-12-20
Q3 2017 $5.48B $1.04B -$99M -8.68% Jun 1, 2017 Aug 31, 2017 10-K 2019-10-28
Q2 2017 $5.58B $1.52B -$16M -1.04% Mar 1, 2017 May 31, 2017 10-Q 2018-06-28
Q1 2017 $5.6B $1.48B -$381M -20.5% Dec 1, 2016 Feb 28, 2017 10-Q 2018-03-28
Q4 2016 $5.98B $1.45B -$21M -1.43% Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-04
Q3 2016 $6B $1.14B +$304M +36.4% Jun 1, 2016 Aug 31, 2016 10-K 2018-10-11
Q2 2016 $5.7B $1.53B +$132M +9.42% Mar 1, 2016 May 31, 2016 10-Q 2017-06-29
Q1 2016 $5.57B $1.86B +$483M +35.1% Dec 1, 2015 Feb 29, 2016 10-Q 2017-04-05
Q4 2015 $5.08B $1.47B +$414M +39.3% Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-05
Q3 2015 $4.67B $836M Jun 1, 2015 Aug 31, 2015 10-K 2017-10-25
Q2 2015 $1.4B +$377M +36.8% Mar 1, 2015 May 31, 2015 10-Q 2016-07-06
Q1 2015 $1.38B +$160M +13.1% Dec 1, 2014 Feb 28, 2015 10-Q 2016-04-05
Q4 2014 $1.05B Sep 1, 2014 Nov 30, 2014 10-Q 2016-01-07
Q2 2014 $1.02B Mar 1, 2014 May 31, 2014 10-Q 2015-07-09
Q1 2014 $1.22B Dec 1, 2013 Feb 28, 2014 10-Q 2015-04-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.